HERMES PHARMA to Invest €25 million to Increase its Manufacturing Capabilities

Specifications:

Name:

HERMES PHARMA to Invest €25 million to Increase its Manufacturing Capabilities

Location:

Pullach, Germany

Company:

HERMES PHARMA

Estimated Cost:

€25 million

Source:

https://www.hermes-pharma.com/

Introduction:

HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has announced it will invest €25 million to further bolster its manufacturing capabilities.

Features:

The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. As a result, HERMES PHARMA will be able to further drive future growth, while helping new and existing customers to realize theirs.

More specifically, the investment will add

• new, large-volume coating equipment to support growing need for advanced taste-masking
• new filling and packaging lines for ODGs and instant drinks
• expanded Good Manufacturing Practice (GMP) manufacturing space
• greater GMP storage capacity
• optimized flow of inventory/goods on the shop floor